Leukemia News

The FDA approved revumenib for the treatment of certain patients with advanced acute leukemia.

Women diagnosed with a hematologic malignancy during pregnancy had a 22-fold higher rate of severe maternal morbidity than those who did not have blood cancer, according to study results.

Healio spoke with John Molina, MD, MEd, about research updates on the use of immunotherapy in leukemia from this year’s Society of Hematologic Oncology Annual Meeting.

The FDA has approved obecabtagene autoleucel for the treatment of adults with relapsed refractory B-cell precursor acute lymphoblastic leukemia.

Healio spoke with John Molina, MD, MEd, about research on the use of minimal residual disease testing in acute lymphoblastic leukemia presented at Society of Hematologic Oncology Annual Meeting.

The FDA granted accelerated approval to asciminib for the treatment of adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.

The FDA has expanded the approval of an oral liquid methotrexate solution to include children and adolescents with polyarticular juvenile idiopathic arthritis and acute lymphoblastic leukemia, according to a press release.

Disparities in hematopoietic stem cell transplantation utilization for blood cancers have narrowed over time but still persist, according to study results.

A new initiative to rapidly place individuals with acute myeloid leukemia or myelodysplastic syndrome in clinical trials based on their genomic profiles has opened in the United States and Canada.